News & Insights
Sort By
Client News 8 Results
Client News
|October 8, 2024
City Therapeutics Announces Launch with $135M Series A Financing
City Therapeutics announces its launch and $135 million Series A financing led by ARCH Ventures
Client News
|July 24, 2024
Gunderson Dettmer Client JenaValve Enters Agreement to be Acquired by Edwards Lifesciences
Pioneer in the transcatheter treatment of aortic regurgitation (AR), JenaValve Technology, announces its agreement to be acquired by Edwards Lifesciences
Client News
|April 24, 2024
AtaCor Medical Announces $28M Series C Financing
Medical device company transforming cardiac pacing and defibrillation lead technology, AtaCor Medical, announces its $28 million Series C financing.
Firm News 3 Results
Firm News
|August 15, 2024
Best Lawyers Recognizes 29 Gunderson Dettmer Attorneys in the 2025 Best Lawyers in America Guide
29 Gunderson Dettmer attorneys were recognized in Best Lawyers' 2025 Best Lawyers in America Guide
Firm News
|August 17, 2023
Best Lawyers Recognizes 25 Gunderson Dettmer Attorneys in the 2024 Best Lawyers in America Guide
Best Lawyers named 25 Gunderson Dettmer attorneys to its 2024 edition of The Best Lawyers in America.
Firm News
|September 6, 2022
Best Lawyers Recognizes 19 Gunderson Dettmer Attorneys as 2023 Best Lawyers in America
Gunderson Dettmer recognized as 2023 Best Lawyers in America by Best Lawyers.